β-catenin-TCF/LEF signaling promotes steady-state and emergency granulopoiesis via G-CSF receptor upregulation.

The canonical Wnt signaling pathway is mediated by interaction of b-catenin with the TCF/LEF transcription factors and subsequent transcription activation of Wnt-target genes. In the hematopoietic system, the function of the pathway has been mainly investigated by rather unspecific genetic manipulations of b-catenin that yielded contradictory results. Here, we employed a mouse expressing a truncated dominant negative form of the human TCF4 transcription factor (dnTCF4) which specifically abrogates b-catenin-TCF/LEF interaction. Disruption of the b-catenin-TCF/LEF interaction resulted in the accumulation of immature cells and reduced granulocytic differentiation. Mechanistically, dnTCF4 progenitors exhibited downregulation of the Csf3r gene, reduced G-CSF receptor levels, attenuation of downstream Stat3 phosphorylation after G-CSF treatment, and impaired G-CSF-mediated differentiation. Chromatin immunoprecipitation assays confirmed direct binding of TCF/LEF factors to the promoter and putative enhancer regions of CSF3R. Inhibition of b-catenin signaling compromised activation of the emergency granulopoiesis program, which requires maintenance and expansion of myeloid progenitors. Consequently, dnTCF4 mice were more susceptible to Candidaalbicans infection and more sensitive to 5-fluorouracil-induced granulocytic regeneration. Importantly, genetic and chemical inhibition of b-catenin-TCF/LEF signaling in human CD34+ cells reduced granulocytic differentiation, whereas its activation enhanced myelopoiesis. Altogether, our data indicate that the b-catenin-TCF/LEF complex directly regulates G-CSF receptor levels, and consequently controls proper differentiation of myeloid progenitors into granulocytes in steady-state and emergency granulopoiesis. Our results uncover a role for the b-catenin signaling pathway in fine tuning the granulocytic production, opening venues for clinical intervention that require enhanced or reduced production of neutrophils.

[1]  H. Kestler,et al.  Differences in expression and function of LEF1 isoforms in normal versus leukemic hematopoiesis , 2019, Leukemia.

[2]  J. Martens,et al.  RUNX1 mutations enhance self-renewal and block granulocytic differentiation in human in vitro models and primary AMLs. , 2019, Blood advances.

[3]  D. Tenen,et al.  C/EBPγ is dispensable for steady-state and emergency granulopoiesis , 2018, Haematologica.

[4]  M. Manz,et al.  Regulation of Inflammation- and Infection-Driven Hematopoiesis. , 2017, Trends in immunology.

[5]  S. Armstrong,et al.  Myeloid progenitor cluster formation drives emergency and leukemic myelopoiesis , 2017, Nature.

[6]  Weiqun Peng,et al.  Hematopoietic and Leukemic Stem Cells Have Distinct Dependence on Tcf1 and Lef1 Transcription Factors* , 2016, The Journal of Biological Chemistry.

[7]  M. Vojtěchová,et al.  Wnt Signaling Inhibition Deprives Small Intestinal Stem Cells of Clonogenic Capacity , 2016, Genesis.

[8]  H. Nakauchi,et al.  Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients , 2014, Leukemia.

[9]  Pierre Baldi,et al.  The TCF C-clamp DNA binding domain expands the Wnt transcriptome via alternative target recognition , 2014, Nucleic acids research.

[10]  M. Heikenwalder,et al.  Endothelial cells translate pathogen signals into G-CSF-driven emergency granulopoiesis. , 2014, Blood.

[11]  W. Nauseef,et al.  Neutrophils at work , 2014, Nature Immunology.

[12]  K. Welte,et al.  Bortezomib inhibits STAT5-dependent degradation of LEF-1, inducing granulocytic differentiation in congenital neutropenia CD34(+) cells. , 2014, Blood.

[13]  Markus G. Manz,et al.  Emergency granulopoiesis , 2014, Nature Reviews Immunology.

[14]  Hao Yuan Kueh,et al.  Positive Feedback Between PU.1 and the Cell Cycle Controls Myeloid Differentiation , 2013, Science.

[15]  Jian-Bing Fan,et al.  The transcriptional architecture of early human hematopoiesis identifies multilevel control of lymphoid commitment , 2013, Nature Immunology.

[16]  Avi Ma'ayan,et al.  Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool , 2013, BMC Bioinformatics.

[17]  N. Shime,et al.  C/EBPβ Is Involved in the Amplification of Early Granulocyte Precursors during Candidemia-Induced “Emergency” Granulopoiesis , 2012, The Journal of Immunology.

[18]  Hans Clevers,et al.  Wnt/β-Catenin Signaling and Disease , 2012, Cell.

[19]  M. Gerstein,et al.  Tcf7 Is an Important Regulator of the Switch of Self-Renewal and Differentiation in a Multipotential Hematopoietic Cell Line , 2012, PLoS genetics.

[20]  Frank J T Staal,et al.  Canonical wnt signaling regulates hematopoiesis in a dosage-dependent fashion. , 2011, Cell stem cell.

[21]  M. Hallek,et al.  Small Molecule Inhibitors of Wnt/β-Catenin/Lef-1 Signaling Induces Apoptosis in Chronic Lymphocytic Leukemia Cells In Vitro and In Vivo , 2010 .

[22]  F. Staal,et al.  Wnt signaling in hematopoiesis: Crucial factors for self‐renewal, proliferation, and cell fate decisions , 2010, Journal of cellular biochemistry.

[23]  A. Hecht,et al.  Alternative splicing of Tcf7l2 transcripts generates protein variants with differential promoter-binding and transcriptional activation properties at Wnt/β-catenin targets , 2009, Nucleic acids research.

[24]  B. K. Thakur,et al.  Neutrophil elastase is severely down-regulated in severe congenital neutropenia independent of ELA2 or HAX1 mutations but dependent on LEF-1. , 2009, Blood.

[25]  Frank J T Staal,et al.  Wnt3a deficiency irreversibly impairs hematopoietic stem cell self-renewal and leads to defects in progenitor cell differentiation. , 2009, Blood.

[26]  D. Scadden,et al.  Wnt signaling in the niche enforces hematopoietic stem cell quiescence and is necessary to preserve self-renewal in vivo. , 2008, Cell stem cell.

[27]  W. Birchmeier,et al.  Long-term, multilineage hematopoiesis occurs in the combined absence of beta-catenin and gamma-catenin. , 2008, Blood.

[28]  H. Macdonald,et al.  Simultaneous loss of β- and γ-catenin does not perturb hematopoiesis or lymphopoiesis , 2008 .

[29]  T. Reya,et al.  Loss of β-Catenin Impairs the Renewal of Normal and CML Stem Cells In Vivo , 2007 .

[30]  K. Zaret,et al.  Repression by Groucho/TLE/Grg proteins: genomic site recruitment generates compacted chromatin in vitro and impairs activator binding in vivo. , 2007, Molecular cell.

[31]  A. Syed,et al.  A Unique DNA Binding Domain Converts T-Cell Factors into Strong Wnt Effectors , 2007, Molecular and Cellular Biology.

[32]  Hans Clevers,et al.  Wnt/β-Catenin Signaling in Development and Disease , 2006, Cell.

[33]  F. Rosenbauer,et al.  Hematopoietic stem cell and multilineage defects generated by constitutive β-catenin activation , 2006, Nature Immunology.

[34]  A. Schambach,et al.  LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia , 2006, Nature Medicine.

[35]  B. Porse,et al.  Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block , 2006, Nature Immunology.

[36]  K. Garrett,et al.  Constitutively active beta-catenin confers multilineage differentiation potential on lymphoid and myeloid progenitors. , 2005, Immunity.

[37]  S. Morrison,et al.  Supplemental Experimental Procedures , 2022 .

[38]  I. Weissman,et al.  Frizzled 9 knock-out mice have abnormal B-cell development. , 2005, Blood.

[39]  W. Weis,et al.  β-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation , 2005, Nature Structural &Molecular Biology.

[40]  H. Macdonald,et al.  β-Catenin Is Dispensable for Hematopoiesis and Lymphopoiesis , 2004, The Journal of experimental medicine.

[41]  Frank Petersen,et al.  Small-molecule antagonists of the oncogenic Tcf/β-catenin protein complex , 2004 .

[42]  W. Birchmeier,et al.  Deletion of β-catenin impairs T cell development , 2003, Nature Immunology.

[43]  I. Weissman,et al.  Wnt proteins are lipid-modified and can act as stem cell growth factors , 2003, Nature.

[44]  I. Weissman,et al.  A role for Wnt signalling in self-renewal of haematopoietic stem cells , 2003, Nature.

[45]  Karine Hovanes,et al.  A New β-Catenin-dependent Activation Domain in T Cell Factor* 210 , 2003, The Journal of Biological Chemistry.

[46]  Hans Clevers,et al.  The β-Catenin/TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer Cells , 2002, Cell.

[47]  T. Matsuda,et al.  Lymphoid Enhancer-Binding Factor-1 Binds and Activates the Recombination-Activating Gene-2 Promoter Together with c-Myb and Pax-5 in Immature B Cells1 , 2002, The Journal of Immunology.

[48]  C. Westbrook,et al.  Novel transcription factors in human CD34 antigen-positive hematopoietic cells. , 2002, Blood.

[49]  P. Seeburg,et al.  Codon‐improved Cre recombinase (iCre) expression in the mouse , 2002, Genesis.

[50]  H. Clevers,et al.  The β-catenin–TCF-1 pathway ensures CD4+CD8+ thymocyte survival , 2001, Nature Immunology.

[51]  D. V. Berg,et al.  Role of Members of the Wnt Gene Family in Human Hematopoiesis , 1998 .

[52]  Hans Clevers,et al.  The Xenopus Wnt effector XTcf-3 interacts with Groucho-related transcriptional repressors , 1998, Nature.

[53]  J. Walsh,et al.  PU.1 regulates both cytokine‐dependent proliferation and differentiation of granulocyte/macrophage progenitors , 1998, The EMBO journal.

[54]  B. Löwenberg,et al.  Perturbed granulopoiesis in mice with a targeted mutation in the granulocyte colony-stimulating factor receptor gene associated with severe chronic neutropenia. , 1998, Blood.

[55]  T. Austin,et al.  A role for the Wnt gene family in hematopoiesis: expansion of multilineage progenitor cells. , 1997, Blood.

[56]  K. Kinzler,et al.  Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC−/− Colon Carcinoma , 1997, Science.

[57]  D. Tenen,et al.  Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[58]  K. Welte,et al.  Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. , 1995, The New England journal of medicine.

[59]  Yoshiya Tanaka,et al.  Abnormal responses of myeloid progenitor cells to recombinant human colony-stimulating factors in congenital neutropenia , 1990 .

[60]  K. Welte,et al.  Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia. , 1990, Blood.